Ascites Hepatic Clinical Trial
Official title:
Health-related Quality of Life Outcomes and Changes in Sarcopenia in Patients With Refractory Ascites
Clinical data regarding quality of life in patients with refractory ascites is limited and preceded the development of newer questionnaires that may be more robust. One primary objective of this study is to study changes in quality in life in a prospective fashion using newer general and ascites-specific quality of life survey instruments specific to benign and malignant etiologies. Sarcopenia is a condition that is prevalent in cancer and cirrhosis. Current data is retrospective and associative, evaluating heterogeneous patient populations at different stages within the timeline of refractory ascites. The other primary objective of this study is to study sarcopenia in a prospective fashion and to understand its kinetics once a patient develops refractory ascites. Prospectively-obtained measures of deterioration in patient-reported outcomes and in muscle mass will form the basis for the next stage of investigation of interventions to mitigate these declines.
Patients with refractory ascites defined as requiring >1 paracentesis within a 6 week period will be prospectively enrolled. The Patient-Reported Outcomes Measurement Information System (PROMIS-10) and ascites-specific (Ascites Q and Edmonton Symptom Assessment System: Ascites Modification) quality of life questionnaires will be obtained at baseline, then at 1-, 2-, 4- and 6 months. Sarcopenia will be assessed by muscle area measurement from a single CT image at the L4 level at baseline, 2- and 6 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
| Recruiting |
NCT05793983 -
S100A8/A9 and Innate Immunity in Liver Disease
|
||
| Recruiting |
NCT05928624 -
A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients
|
N/A | |
| Recruiting |
NCT04221672 -
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
|
Phase 3 | |
| Completed |
NCT04384523 -
A Study of OsrHSA in Adult Healthy Male and Female Volunteers
|
Phase 1 | |
| Recruiting |
NCT05346393 -
HRS-AKI Treatment With TIPS in Patients With Cirrhosis
|
N/A | |
| Recruiting |
NCT04322201 -
Continuous Passive Paracentesis for Intra-abdominal Hypertension
|
N/A | |
| Completed |
NCT05013502 -
Empagliflozin in Diuretic Refractory Ascites
|
Phase 1 | |
| Withdrawn |
NCT04109144 -
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis
|
Phase 2 | |
| Completed |
NCT04569565 -
Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites
|
N/A | |
| Completed |
NCT03459378 -
Outcome After TIPS
|
||
| Recruiting |
NCT06256432 -
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
|
Phase 2 | |
| Recruiting |
NCT05999773 -
SGLT-2 Inhibitors in the Treatment of Ascites
|
||
| Completed |
NCT03107091 -
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
|
Phase 2 | |
| Terminated |
NCT05765253 -
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
|
N/A | |
| Recruiting |
NCT05960006 -
A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis
|
||
| Completed |
NCT03191851 -
Evaluation of 'Melody' Paracentesis Device for Ascites Therapy
|
N/A | |
| Recruiting |
NCT05490888 -
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
|
Phase 1 | |
| Not yet recruiting |
NCT06224023 -
Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
|
||
| Terminated |
NCT03027635 -
PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
|
N/A |